PubPharm - Specialised Information Services for Pharmacy

药房专业信息服务（SIS）以药物为中心的搜索引擎及其创新服务将继续作为PubPharm的中央基础设施。此外，所有服务将整合到一个单一入口点，即新的综合平台www.pubpharm.de。大学图书馆和布伦瑞克工业大学信息系统研究所之间的合作导致了科学界确认的具有创新性质的生产性服务。这些服务，例如基于实体的情境化和语义分面以及可视化实体网络（药物-靶点-疾病网络），经常用于药物研究工作流程。信息技术研究以及信息基础设施与计算机科学之间的密切合作已被证明是尖端的和模型的建立。 在第三个资助期内，创新服务研究的新挑战将得到解决。例如，基于出版物和专家数据库中嵌入的知识预测药物和其他生物活性化合物之间的相互作用，对新发表的科学结果进行可行性检查，以及通过更好地解释基于AI的工具的输出来改善用户体验。此外，叙事信息访问提供了一个精确的搜索，利用变量的论证结构在科学文献中。基于这项研究，智能工具的开发，由科学界评估，并集成到PubPharm。 一个重大的增强影响了PubPharm的整体架构：所有SIS服务，如新的特定主题存储库pharmRxiv，创新服务和社交媒体渠道的工作流程，将嵌入PubPharm。此外，将建立可扩展的数字流程，用于索引，验证和语义丰富异质科学来源的元数据，如临床研究，专业数据库和研究数据。 来自科学界的密集和系统的反馈保证了PubPharm以需求为基础以及以用户为中心的导向。除了以药物为中心的搜索引擎外，SIS服务的一个重要组成部分是为大学制药科学家提供专业数字期刊。开放获取活动，逆向数字化和长期保存以及研究数据管理咨询补充了SIS的产品组合。

The drug-centred search engine of the Specialised Information Service (SIS) for Pharmacy and its innovative services will be continued as the central infrastructure PubPharm. Furthermore, all services will be integrated into a Single Point of Entry, the new comprehensive platform www.pubpharm.de. The cooperation between the University Library and the Institute for Information Systems of the TU Braunschweig resulted in productive services with innovative character confirmed by the scientific community. These services, e.g. the entity-based contextualization and semantic faceting as well as the visualised entity networks (Drug-Target-Disease Networks), are frequently utilised in pharmaceutical research workflows. Information technology research and the close cooperation between information infrastructure and computer science have proven to be cutting-edge and model-building. New challenges in the research of innovative services will be addressed during the third funding period. Examples are the prediction of interactions between drugs and other bioactive compounds based on knowledge embedded in publications and specialist databases, the plausibility check of newly published scientific results and the improvement of user experience by better explaining the output of AI-based tools. Furthermore, narrative information access offers a precise search utilizing variables for argumentation structures in scientific literature. Based on this research, intelligent tools are developed, evaluated by the scientific community, and integrated into PubPharm. A major enhancement affects the overall architecture of PubPharm: all SIS services, such as the new subject-specific repository pharmRxiv, workflows for innovative services and social media channels, will be embedded in PubPharm. Furthermore, scalable digital processes will be established for indexing, validating and semantically enriching metadata of heterogeneous scientific sources, such as clinical studies, specialised databases and research data. Intensive and systematic feedback from the scientific community guarantees the requirements-based as well as the user-centric orientation of PubPharm. In addition to the drug-centred search engine, an important component of the SIS services is providing specialised digital journals to university-based pharmaceutical scientists. Open access activities, retro-digitization and long-term preservation as well as research data management consulting supplement the SIS portfolio.